XBIO vs ZTS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
XBIO
ZTS
Investment Advisor Scores
ZTS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XBIO | ZTS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 11.9904 | Tie |
| PEG Ratio | 0 | 6.6639 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 12.0% | -0.2% | XBIO |
| Earnings Growth | 0.0% | 1.2% | ZTS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.5/100 | 24.4/100 | XBIO |
| Profit Margin | -75.9% | 27.7% | ZTS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG SELL | XBIO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XBIO
MarkdownPrice below a falling SMA50 (slope -8.6%), weak momentum, RSI 28
ZTS
NeutralMixed signals - no dominant trend phase, RSI 69
Fundamentals Snapshot
| Metric | XBIO | ZTS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.1 | 12.6 |
| Trailing P/E | — | 13.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 1.0% | 0.7% |
| Operating Margin | -1.5% | 0.4% |
| EPS | -1.09 | 6.08 |
| Dividend Yield | — | 0.03% |